(Q40393577)

20 September 2017

1 reference

title

Marker antibodies of rheumatoid arthritis: diagnostic and pathogenetic implications (English)

1 reference

20 September 2017

Marker antibodies of rheumatoid arthritis: Diagnostic and pathogenetic implications (English)

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

17 May 2024

0 references

0 references

K. Aho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524151

17 May 2024

T. Palusuo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524151

17 May 2024

P. Kurki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7524151

17 May 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7524151

17 May 2024

publication date

1 June 1994

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:0049017294900884?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

https://api.elsevier.com/content/article/PII:0049017294900884?httpAccept=text/plain

17 May 2024

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Seminars in Arthritis and Rheumatism

17 May 2024

published in

1 reference

20 September 2017

23

1 reference

20 September 2017

6

1 reference

20 September 2017

379-387

1 reference

ON THE OCCURRENCE OF A FACTOR IN HUMAN SERUM ACTIVATING THE SPECIFIC AGGLUTINATION OF SHEEP BLOOD CORPUSCLES

20 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

17 May 2024

Rheumatoid factors

3

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from patients with rheumatoid arthritis

17 May 2024

4

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Anti-keratin antibodies in rheumatoid arthritis

17 May 2024

5

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'.

17 May 2024

6

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin

17 May 2024

7

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease

17 May 2024

9

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Prospect for an additional laboratory criterion for rheumatoid arthritis

17 May 2024

10

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

17 May 2024

11

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process

17 May 2024

13

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis

17 May 2024

14

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

DEMONSTRATION OF A NEW ANTINUCLEAR FOR RHEUMATOID ARTHRITIS ANTIBODY (ANTI-RA33) THAT IS HIGHLY SPECIFIC

17 May 2024

15

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex

17 May 2024

17

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid arthritis: can the long-term outcome be altered?

17 May 2024

18

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

50 years of antirheumatic therapy: the prognosis of rheumatoid arthritis

17 May 2024

19

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid arthritis. Pathophysiology and implications for therapy

17 May 2024

20

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Epidemiology of rheumatoid arthritis

17 May 2024

22

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Clinical arthritis associated with positive radiological and serological findings in Finnish adults

17 May 2024

23

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

The rheumatoid factor: an analysis of clinical utility

17 May 2024

24

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

THE RHEUMATOID FACTOR IN DEFINITE RHEUMATOID ARTHRITIS. AN ANALYSIS OF 1279 ADULT PATIENTS, WITH A FOLLOW-UP STUDY

17 May 2024

25

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Is seropositive rheumatoid arthritis becoming less severe?

17 May 2024

26

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis

17 May 2024

27

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up.

17 May 2024

29

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome

17 May 2024

30

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Significance of rheumatoid factors in an eight-year longitudinal study on arthritis

17 May 2024

31

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

When does rheumatoid disease start?

17 May 2024

33

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid factors antedating clinical rheumatoid arthritis

17 May 2024

34

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

The incidence of rheumatoid arthritis is predicted by rheumatoid factor titer in a longitudinal population study

17 May 2024

35

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis.

17 May 2024

36

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Autoantibodies to cartilage collagens in rheumatoid arthritis. Do they perpetuate the disease or are they irrelevant?

17 May 2024

37

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Antibodies against native type II collagen do not precede the clinical onset of rheumatoid arthritis.

17 May 2024

38

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Demonstration of antiglobulin activity in the synovial membrane of patients with rheumatoid arthritis and ankylosing spondylitis after pepsin treatment: real or artefact?

17 May 2024

39

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis

17 May 2024

41

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

C-reactive protein in population samples

17 May 2024

42

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

The distribution of class-specific rheumatoid factors is similar in rheumatoid and pre-illness sera

17 May 2024

43

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Antibodies to synthetic peptides from Epstein-Barr nuclear antigen-1 in sera of patients with early rheumatoid arthritis and in preillness sera

17 May 2024

44

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Occurrence of two germline-related rheumatoid factor idiotypes in rheumatoid arthritis and in non-rheumatoid seropositive individuals

17 May 2024

45

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Increased frequencies of Sm and nRNP autoantibodies in American blacks compared to whites with systemic lupus erythematosus

17 May 2024

46

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study

17 May 2024

47

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid arthritis in sub-Saharan Africa

17 May 2024

49

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid factor seroconversions in relation to clinical rheumatoid arthritis

17 May 2024

50

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Population study of the importance of rheumatoid factor isotypes in adults

17 May 2024

51

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Smoking, lung function, and rheumatoid factors

17 May 2024

52

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Hypothesis: rheumatoid factors are antiidiotypes related to bacterial or viral Fc receptors

17 May 2024

54

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Selective induction of rheumatoid factors by superantigens and human helper T cells

17 May 2024

55

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid factor-like immunoglobulin M protects previously uninfected rat pups and dams from Trypanosoma lewisi.

17 May 2024

57

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Immune complex formation between IgM rheumatoid factor and IgG generated by hyaluronic acid

17 May 2024

60

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response

17 May 2024

61

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid factor isotypes in patients with rheumatoid arthritis and in subjects with "false-positive" reactions

17 May 2024

63

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Estimation of the relative avidity of 19S IgM rheumatoid factor secreted by rheumatoid synovial cells for human IgG subclasses

17 May 2024

64

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Demonstration of a cross-reactive idiotype (IdRQ) in rheumatoid factors from patients with rheumatoid arthritis but not in rheumatoid factors from healthy, aged subjects

17 May 2024

65

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus

17 May 2024

66

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes

17 May 2024

67

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Rheumatoid factor detection in the unaffected first degree relatives in families with multicase rheumatoid arthritis

17 May 2024

69

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Mixed lymphocyte reaction in healthy women with rheumatoid factor. lack of association with hla‐dw4

17 May 2024

70

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population

17 May 2024

71

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

The prevalence of HLA-DR4 and HLA-DR3 in healthy persons with rheumatoid factor

17 May 2024

72

1 reference

https://api.crossref.org/works/10.1016/0049-0172(94)90088-4

17 May 2024

Identifiers

1 reference

20 September 2017

1 reference